Citation Impact
Citing Papers
Endothelial Heparan Sulfate Proteoglycan. I. Inhibitory Effects on Smooth Muscle Cell Proliferation
1990
Impaired immune and acute-phase responses in interleukin-6-deficient mice
1994 StandoutNatureNobel
Simultaneous production of interleukin 6, interferon‐β and colony‐stimulating activity by fibroblasts after viral and bacterial infection
1989
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
The p53 proto-oncogene can act as a suppressor of transformation
1989 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Mesenchymal stem cells
1991 Standout
Interleukin-6 in Biology and Medicine
1993
Exercise Standards for Testing and Training
2013 Standout
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
What does Stat3 do?
2002 Standout
Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice
2004 Standout
Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
2000
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Purification and characterization of human fibroblast‐derived hybridoma growth factor identical to T‐cell‐derived B‐cell stimulatory factor‐2 (interleukin‐6)
1987
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
2003 Standout
THE EFFECT OF HUMAN ENDOTHELIAL CELL‐DERIVED PROTEOGLYCANS ON HUMAN SMOOTH MUSCLE CELL GROWTH
1997
Monoclonal antibodies to the major feline allergen Fel d I
1988
The Antiphospholipid Syndrome
2002 Standout
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
2003 Standout
Sensitive ELISA for interleukin-6
1991
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Control of angiogenesis by the pericyte: Molecular mechanisms and significance
1997
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Production of hybridoma growth factor by human monocytes
1987
The STATs of cancer — new molecular targets come of age
2004 Standout
Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion on subendothelium is not collagen.
1988
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Slow upsloping ST-segment depression during exercise: Does it really signify a positive stress test?
2002
Modes of resistance to anti-angiogenic therapy
2008 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Homocysteine and Atherothrombosis
1998 Standout
Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation
1989
Interleukin-6 production in posttransplant lymphoproliferative disease.
1993
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Epstein–Barr Virus Infection
2000 Standout
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Interleukin-6: An Overview
1990 Standout
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
1989 Standout
Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human.
1988
Prostacyclin production by cultured endothelial cell monolayers exposed to step increases in shear stress.
1985
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C.
1993
Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells.
1993 Standout
Small GTP-Binding Proteins
2001 Standout
Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism.
1989
Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells
1990 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
A vascular endothelial cell antigen with restricted distribution in human foetal, adult and malignant tissues.
1983
Preparation of cell-affinity adsorbents by immobilization of peptides to Sephadex G-10
1995
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Interleukin-6 and the acute phase response
1990 Standout
A mouse monoclonal antibody detecting a DR-related MT2-like specificity: Serology and biochemistry
1984
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
1992 Standout
Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium
1996 StandoutNobel
Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
1992
Interleukin 1 and poly(rI) · poly(rC) induce production of a hybridoma growth factor by human fibroblasts
1987
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
1986
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1
1985
Endothelial cell dysfunction in homocystinuria
1983
Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors
2000 Standout
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
1996 Standout
Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans
1996
Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation
1989
Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.
1987
Leukocyte-endothelial adhesion molecules
1994 Standout
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
Immunologic detection of endothelial cells in human whole blood
1991
Localization of the E1 B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies
1985
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
1991 Standout
Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation
1987
Interleukin 6: A Multifunctional Cytokine Regulating Immune Reactions and the Acute Phase Protein Response
1990
Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
1991
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]
1993
Endogenous release of hepoxilin A3 from isolated perifused pancreatic islets of Langerhans
1985 StandoutNobel
Identification of osteocytes in osteoblast-like cell cultures using a monoclonal antibody specifically directed against osteocytes
1986
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
1998 Standout
Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regulation by epidermal growth factor.
1985
Interleukin-1 and interleukin-1 antagonism
1991 Standout
A murine monoclonal IgM antibody specific for blood group P antigen (globoside)
1986
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
1991 Standout
Effects of inhibitors of eicosanoid synthesis on insulin release by neonatal pancreatic islets
1984
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
1993 StandoutScience
Human lymphocyte Hybridomas and Monoclonal Antibodies
1986
Flow-mediated endothelial mechanotransduction
1995 Standout
CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells.
1992
Works of C Willems being referenced
Pulmonary uptake of sestamibi on early post-stress images
1993
Arachidonate metabolism in cultured human vascular endothelial cells
1982
Human endothelial culture supernatant (HECS): a growth factor for hybridomas.
1980
Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells
1982
Production of Prostacyclin by Vascular Endothelial Cells
1979
Human endothelial culture supernatant (HECS): evidence for a growth-promoting factor binding to hybridoma and myeloma cells.
1981
Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
1982